bluebird bio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Location
Somerville, MA
Fiscal year end
31 December
Latest financial report
14 May 2025

Quick Takeaways

  • bluebird bio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2025.
  • Headline metric: Return On Equity -547%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+283%</span>.
  • Most recent SEC facts end date: 31 Mar 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-03-31) highlights Return On Equity -546.5%, Return On Assets -43.1%, and Operating Margin -208.2%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

36.9/100

Weak Confidence high

Return On Equity

-547%

Metric score 0.0/100

Return On Assets

-43%

Metric score 0.0/100

Financial Health

Current Ratio
0.55x
Quick Ratio
0.29x
Debt to Equity
-42.85x

Strengths

Revenues YoY and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-547%

YoY: +283%

Industry median: -47% (n=218)

View history

Return On Assets

-43%

YoY: -5%

Industry median: -44% (n=217)

View history

Operating Margin

-208%

YoY: -72%

Industry median: -263% (n=94)

View history

Current Ratio

0.55x

YoY: -40%

Industry median: 3.67x (n=218)

View history

Quick Ratio

0.29x

YoY: -65%

Industry median: 2.03x (n=83)

View history

Debt-to-equity

-42.85x

YoY: -1908%

Industry median: 0.31x (n=169)

View history

Revenues YoY

129%

YoY:

Industry median: 11% (n=96)

View history

NetIncomeLoss YoY

33%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -547% +283%
Return On Assets -43% -5%
Operating Margin -208% -72%

Financial Health

Metric Latest value YoY change
Current Ratio 0.55x -40%
Quick Ratio 0.29x -65%
Debt-to-equity -42.85x -1908%

Growth

Metric Latest value YoY change
Revenues YoY 129%
NetIncomeLoss YoY 33%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 9,790,070
Common Stock, Shares, Outstanding 9,790,000 -95%
Common Stock, Value, Issued $1,924,000 +0.58%
Weighted Average Number of Shares Outstanding, Basic 9,751,000 +0.96%
Weighted Average Number of Shares Outstanding, Diluted 9,751,000 +0.96%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $103,946,000 +129%
Cost of Revenue $75,753,000 +41%
Research and Development Expense $86,901,000 -43%
Costs and Expenses $244,569,000 -25%
Operating Income (Loss) $216,376,000 +35%
Income Tax Expense (Benefit) $170,000
Earnings Per Share, Basic -21 +55%
Earnings Per Share, Diluted -21 +55%
Cash and Cash Equivalents, at Carrying Value $78,744,000 -63%
Inventory, Net $83,283,000 +175%
Assets, Current $174,524,000 -36%
Property, Plant and Equipment, Net $60,405,000 -33%
Operating Lease, Right-of-Use Asset $27,073,000 -86%
Intangible Assets, Net (Excluding Goodwill) $9,315,000 -9.1%
Goodwill $5,646,000 0%
Other Assets, Noncurrent $18,994,000 -67%
Assets $295,957,000 -53%
Accounts Payable, Current $42,624,000 +120%
Employee-related Liabilities, Current $15,904,000 +46%
Liabilities, Current $315,078,000 +7.3%
Operating Lease, Liability, Noncurrent $23,571,000 -87%
Other Liabilities, Noncurrent $92,000 0%
Liabilities $353,823,000 -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,879,000 +11%
Retained Earnings (Accumulated Deficit) $4,530,112,000 -4.6%
Stockholders' Equity Attributable to Parent $57,866,000 -144%
Liabilities and Equity $295,957,000 -53%
Other Noncash Income (Expense) $235,000 +2250%
Share-based Payment Arrangement, Noncash Expense $1,660,000 -56%
Net Cash Provided by (Used in) Operating Activities $43,442,000 +42%
Net Cash Provided by (Used in) Financing Activities $26,709,000 -59%
Net Cash Provided by (Used in) Investing Activities $3,102,000
Common Stock, Shares Authorized 250,000,000 0%
Common Stock, Shares, Issued 9,790,000 -95%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,631,000 -28%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $92,312,000 -65%
Operating Lease, Liability $28,538,000 -86%
Payments to Acquire Property, Plant, and Equipment $859,000 -52%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $199,751,000 +33%
Lessee, Operating Lease, Liability, to be Paid $35,210,000 -86%
Operating Lease, Liability, Current $4,967,000 -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,187,000 -85%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,053,000 -86%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,672,000 -87%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,324,000 -86%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,821,000 -90%
Operating Lease, Payments $4,432,000 +56%
Additional Paid in Capital $4,472,201,000 +0.24%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $11,635,000 -35%
Preferred Stock, Par or Stated Value Per Share 0.01 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY